Clinical Trial Update: Gossypol Acetic Acid in Treating Patients With Recurrent, Metastatic, or Primary Adrenocortical Cancer That Cannot Be Removed By Surgery [Phase 2]

View source ↗

Summary

Phase 2 trial of gossypol acetic acid in patients with recurrent, metastatic, or primary adrenocortical carcinoma that cannot be surgically removed has complete…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Adrenocortical Carcinoma

Drugs mentioned

• Gossypol acetic acid (gossypol acetic acid)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Recurrent Adrenocortical Carcinoma, Stage III Adrenocortical Carcinoma | Phase 2 | Status: COMPLETED | Results posted: 2014-02-21